Inactive Instrument

Other languages POIT BIOP

Equities

RACA

US7305411099

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Fusion Pharmaceuticals an 'Attractive' Takeover Target Following Recent Radiopharma Deals, Oppenheimer Says	Dec. 27
Fusion Pharmaceuticals 'Last Available Target' With Solid Supply Chain After Point Biopharma, RayzeBio Takeovers, Oppenheimer Says	Dec. 27
Swiss Shares Decline Amid Lingering Concerns for Growth of Local Economy	Dec. 27
Eli Lilly : succès de l'OPA sur POINT Biopharma Global	Dec. 27
Williams : Eli Lilly, Williams Cos...les valeurs à suivre aujourd'hui à Wall Street	Dec. 27
Eli Lilly Completes Acquisition of Point Biopharma Global	Dec. 27
Eli Lilly and : finalise le rachat de Point Biopharma	Dec. 27
Eli Lilly and Company completed the acquisition of POINT Biopharma Global Inc. from Joe A. McCann, Allan Charles Silber, Neil E. Fleshner and others.	Dec. 26
Lantheus, POINT Biopharma Say Trial of 177Lu-PNT2002 for Metastatic Castration-Resistant Prostate Cancer Meets Endpoint	Dec. 18
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition to Dec. 22	Dec. 18
Eli Lilly : prolonge encore l'OPA sur Point Biopharma Global	Dec. 18
Lantheus Holdings, Inc. and POINT Biopharma Global Inc. Announce Positive Topline Results from Pivotal Splash Trial in Metastatic Castration-Resistant Prostate Cancer	Dec. 18
Eli Lilly Further Extends Tender Offer Deadline for Point Biopharma Shares	Dec. 18
Eli Lilly : prolonge à nouveau son OPA sur POINT Biopharma	Dec. 04
Eli Lilly extends tender offer to buy Point Biopharma	Dec. 04
Eli Lilly : a prolongé son OPA sur Point Biopharma	Nov. 20
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition	Nov. 17
Lilly extends tender offer to acquire Point Biopharma to Dec 1	Nov. 17
Eli Lilly Gets Approval for Indirect Transfer of Control of POINT's Radioactive Materials License	Nov. 15
Eli Lilly Wins US Nuclear Regulator's Nod to Transfer Point Biopharma License	Nov. 14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages POIT BIOP

Equities

RACA

US7305411099

Other languages

Filters